Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers…
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced…